Literature DB >> 21219176

Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes.

Christoph Klein1.   

Abstract

The discovery of genetic defects causing congenital neutropenia has illuminated mechanisms controlling differentiation, circulation, and decay of neutrophil granulocytes. Deficiency of the mitochondrial proteins HAX1 and AK2 cause premature apoptosis of myeloid progenitor cells associated with dissipation of the mitochondrial membrane potential, whereas mutations in ELA2/ELANE and G6PC3 are associated with signs of increased endoplasmic reticulum stress. Mutations in the transcriptional repressor GFI1 and the cytoskeletal regulator WASP also lead to defective neutrophil production. This unexpected diversity of factors suggests that multiple pathways are involved in the pathogenesis of congenital neutropenia.

Entities:  

Mesh:

Year:  2011        PMID: 21219176     DOI: 10.1146/annurev-immunol-030409-101259

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  58 in total

1.  Novel ELANE Gene Mutation in a Newborn with Severe Congenital Neutropenia: Case Report and Literature Review.

Authors:  Yue Jia; Changjun Yue; Kathryn Bradford; Xin Qing; Eduard H Panosyan; Moran Gotesman
Journal:  J Pediatr Genet       Date:  2019-11-18

Review 2.  Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis.

Authors:  Lakmali M Silva; Laurie Brenchley; Niki M Moutsopoulos
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

3.  Inherited biallelic CSF3R mutations in severe congenital neutropenia.

Authors:  Alexa Triot; Päivi M Järvinen; Juan I Arostegui; Dhaarini Murugan; Naschla Kohistani; José Luis Dapena Díaz; Tomas Racek; Jacek Puchałka; E Michael Gertz; Alejandro A Schäffer; Daniel Kotlarz; Dietmar Pfeifer; Cristina Díaz de Heredia Rubio; Mehmet Akif Ozdemir; Turkan Patiroglu; Musa Karakukcu; José Sánchez de Toledo Codina; Jordi Yagüe; Ivo P Touw; Ekrem Unal; Christoph Klein
Journal:  Blood       Date:  2014-04-21       Impact factor: 22.113

4.  Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib.

Authors:  Hyun Sik Jun; David A Weinstein; Young Mok Lee; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2014-02-24       Impact factor: 22.113

5.  Validation is a dish oft served cold.

Authors:  David B Wilson
Journal:  Blood       Date:  2014-06-12       Impact factor: 22.113

Review 6.  When Actin is Not Actin' Like It Should: A New Category of Distinct Primary Immunodeficiency Disorders.

Authors:  Evelien G G Sprenkeler; Steven D S Webbers; Taco W Kuijpers
Journal:  J Innate Immun       Date:  2020-08-26       Impact factor: 7.349

7.  Mosaicism of an ELANE mutation in an asymptomatic mother in a familial case of cyclic neutropenia.

Authors:  Osamu Hirata; Satoshi Okada; Miyuki Tsumura; Shuhei Karakawa; Itaru Matsumura; Yujiro Kimura; Toshiro Maihara; Shin'ichiro Yasunaga; Yoshihiro Takihara; Osamu Ohara; Masao Kobayashi
Journal:  J Clin Immunol       Date:  2015-04-26       Impact factor: 8.317

8.  Nuclear-to-cytoplasmic relocalization of the proliferating cell nuclear antigen (PCNA) during differentiation involves a chromosome region maintenance 1 (CRM1)-dependent export and is a prerequisite for PCNA antiapoptotic activity in mature neutrophils.

Authors:  Dikra Bouayad; Magali Pederzoli-Ribeil; Julie Mocek; Céline Candalh; Jean-Benoît Arlet; Olivier Hermine; Nathalie Reuter; Noélie Davezac; Véronique Witko-Sarsat
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

Review 9.  Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Authors:  Christoph Klein
Journal:  J Clin Immunol       Date:  2016-12-10       Impact factor: 8.317

Review 10.  ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Authors:  Marshall S Horwitz; Seth J Corey; H Leighton Grimes; Timothy Tidwell
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-07       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.